This interaction between NKG2A and HLA-E contributes to tumor immune escape; therefore, NKG2A-mediated mechanisms are currently being exploited to develop potential anti-tumor therapeutic strategies [30,34,37]. Here, KLRC1 is linked to neoplasm.